Promising results drive push for Paxlovid compulsory license Dec. 7, 2021 By Mari Serebrov Although Pfizer Inc.’s COVID-19 oral antiviral candidate, Paxlovid (PF-07321332; ritonavir), has yet to be authorized anywhere, the push for compulsory licensing of the drug has begun.Read More
BioWorld MedTech Patent Highlights: Week 47 From Current Patent Gazette Dec. 3, 2021 BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.Read More
RSS